DDX3Y and small cell osteogenic sarcoma: Indeed,DDX3Y has a higher mutation rate in SCOS patients than the other two genes in the AZFa region [20], and DDX3Y proteinlocalization is restricted only in testes, specifically in spermatogonia and early spermatocytes, albeit with low mRNA expression of DDX3Y in various organs [21].